- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
前期的强势行情已经结束，投资者及时卖出股票为为宜。
- 中期趋势：
回落整理中且下跌有加速趋势。
- 长期趋势：
已有2家主力机构披露2025-12-31报告期持股数据，持仓量总计1.25亿股，占流通A股14.18%
- 波段诊断：
-
技术面诊股
诊断结果：3.6技术面打败了35%的股票
技术面评分前10的股票
近期的平均成本为7.19元。多头行情中，目前处于回落整理阶段且下跌有加速趋势。
平均成本
近期的平均成本为7.19元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"7.19","date":1780386789,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，跑赢行业平均水平。
[{"date":"2026.06.03","stock":"-2.32","trade":"-1.10","ind":"0.73"},{"date":"2026.06.02","stock":"2.37","trade":"-2.06","ind":"1.63"},{"date":"2026.06.01","stock":"0.70","trade":"0.40","ind":"-1.51"},{"date":"2026.05.29","stock":"-1.11","trade":"0.36","ind":"-1.81"},{"date":"2026.05.28","stock":"0.00","trade":"-0.71","ind":"0.80"},{"date":"2026.05.27","stock":"-0.83","trade":"-1.05","ind":"-0.88"},{"date":"2026.05.26","stock":"-0.96","trade":"-1.43","ind":"0.12"},{"date":"2026.05.25","stock":"-0.81","trade":"-1.35","ind":"1.66"},{"date":"2026.05.22","stock":"1.51","trade":"0.11","ind":"2.30"},{"date":"2026.05.21","stock":"-2.15","trade":"-1.67","ind":"-2.07"},{"date":"2026.05.20","stock":"0.27","trade":"-0.92","ind":"0.00"},{"date":"2026.05.19","stock":"-0.54","trade":"0.64","ind":"0.26"},{"date":"2026.05.18","stock":"-4.85","trade":"-1.49","ind":"-0.20"},{"date":"2026.05.15","stock":"2.76","trade":"-0.71","ind":"-1.17"},{"date":"2026.05.14","stock":"1.33","trade":"-1.71","ind":"-2.14"},{"date":"2026.05.13","stock":"0.53","trade":"-0.44","ind":"1.67"},{"date":"2026.05.12","stock":"5.06","trade":"-1.41","ind":"-0.47"},{"date":"2026.05.11","stock":"-1.39","trade":"1.65","ind":"2.16"},{"date":"2026.05.08","stock":"2.41","trade":"0.14","ind":"-0.50"},{"date":"2026.05.07","stock":"0.00","trade":"-0.07","ind":"1.18"},{"date":"2026.05.06","stock":"-0.98","trade":"0.78","ind":"2.33"}]
ST景峰,深证成指,化学制药指数
压力支撑
该股压力位为7.22元，支撑位为7.11元。
[{"text":"\u538b\u529b\u4f4d","value":"7.22","date":1780416000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"7.11","date":1780416000,"color":"0x0b52a1"}]
多空趋势
多头行情中，目前处于回落整理阶段且下跌有加速趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.3资金面打败了25%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：06月03日 20:30
| 机构今日流向(万元) | -1472.18 | 机构5日流向(万元) | -4288.75 |
| 机构10日流向(万元) | -10435.67 | 机构20日流向(万元) | -26938.80 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量不变，其中基金数没有增加，主力数没有增加，暂未发现中长期投资价值。
截止2025-12-31，共2家主力机构（一般法人2家），持仓量总计12476.41万股，占流通A股14.18%
其中，基金持仓与2025-06-30相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：0家 ，持有万股
从主力名单中消失：0家 ，原持有万股
其中，基金持仓与2025-06-30相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：0家 ，持有万股
从主力名单中消失：0家 ，原持有万股
消息面诊股
诊断结果：5.7消息面打败了7%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 203家医药企业，销售费用来了（附名单）
2026-05-15 - ST景峰05月12日涨停分析
2026-05-12 - 净利最高大涨4082.41%，142家「创新」概念
2026-05-11 - ST景峰：公司不存在控股股东、实际控制人及关联方非
2026-05-07 - 股东追踪|严辉斌等新进ST景峰前十大流通股东
2026-04-29 - 财报速递：ST景峰2025年全年净亏损8088.9
2026-05-01 - 三人行04月28日涨停分析
2026-04-28 - 涨停雷达：石药入主+创新药+摘星 ST景峰触及涨停
2026-04-28 - 湘股人事密集调整 工作变动、重整等主导“换血”潮
2026-04-22 - 2026年以来湖南2家上市公司完成重整
2026-04-15
消息列表
| 一般消息 | 股东大会 | 年度股东大会 | 2026-05-07 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-04-29 |
| 一般消息 | 高管变动 | 因个人原因 | 2026-04-28 |
| 一般消息 | 高管变动 | 因董事会换届 | 2026-04-02 |
| 利好 | 上市变动 | 公司摘* | 2026-03-26 |
| 利空 | 业绩预告 | 业绩预亏 | 2026-01-30 |
| 一般消息 | 重大事项 | 公司股东股份冻结 | 2026-01-24 |
| 利好 | 分红转增 | 10转10股 | 2026-01-13 |
| 一般消息 | 重大事项 | 关联交易 | 2025-12-31 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-12-30 |
| 一般消息 | 重大事项 | 关联交易 | 2025-12-13 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-10-27 |
| 一般消息 | 重大事项 | 公司股东股份解冻 | 2025-10-24 |
| 利空 | 上市变动 | 特别处理*ST | 2025-10-23 |
| 一般消息 | 重大事项 | 关联交易 | 2025-10-09 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-25 |
| 一般消息 | 重大事项 | 公司股东股份冻结 | 2025-07-22 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 利好 | 上市变动 | 公司摘* | 2025-06-16 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 5条 | 0条 | 5条 |
| 利空 | 2条 | 0条 | 2条 |
行业面诊股
诊断结果：4.8行业面打败了71%的股票
化学制药行业最新资金流向
近10日来该行业走势总体向下，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势总体向下，明显跑输大盘。
[{"date":"2026.06.03","price":"0.73","value":"-1.10"},{"date":"2026.06.02","price":"1.63","value":"-2.06"},{"date":"2026.06.01","price":"-1.51","value":"0.40"},{"date":"2026.05.29","price":"-1.81","value":"0.36"},{"date":"2026.05.28","price":"0.80","value":"-0.71"},{"date":"2026.05.27","price":"-0.88","value":"-1.05"},{"date":"2026.05.26","price":"0.12","value":"-1.43"},{"date":"2026.05.25","price":"1.66","value":"-1.35"},{"date":"2026.05.22","price":"2.30","value":"0.11"},{"date":"2026.05.21","price":"-2.07","value":"-1.67"},{"date":"2026.05.20","price":"0.00","value":"-0.92"},{"date":"2026.05.19","price":"0.26","value":"0.64"},{"date":"2026.05.18","price":"-0.20","value":"-1.49"},{"date":"2026.05.15","price":"-1.17","value":"-0.71"},{"date":"2026.05.14","price":"-2.14","value":"-1.71"},{"date":"2026.05.13","price":"1.67","value":"-0.44"},{"date":"2026.05.12","price":"-0.47","value":"-1.41"},{"date":"2026.05.11","price":"2.16","value":"1.65"},{"date":"2026.05.08","price":"-0.50","value":"0.14"},{"date":"2026.05.07","price":"1.18","value":"-0.07"},{"date":"2026.05.06","price":"2.33","value":"0.78"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 纳微科技 | 24.01% | -0.87% | 5.7分 |
| 2 | 科源制药 | 13.58% | 11.76% | 6.2分 |
| 3 | 东亚药业 | 13.17% | 15.12% | 5.8分 |
| 4 | 翰宇药业 | 6.84% | -9.26% | 5.0分 |
| 5 | 昂利康 | 4.59% | -5.99% | 4.6分 |
| 6 | 必贝特 | 2.81% | -7.31% | 5.2分 |
| 8 | 科伦药业 | 0.03% | -5.97% | 5.7分 |
| 10 | 仙琚制药 | -2.10% | 2.07% | 4.8分 |
| 12 | 东诚药业 | -3.69% | -0.56% | 4.5分 |
| 14 | 国药现代 | -4.45% | 1.58% | 4.8分 |
| 16 | 华海药业 | -4.66% | -3.03% | 4.5分 |
| 18 | 丽珠集团 | -6.17% | -0.03% | 5.1分 |
| 20 | 华润双鹤 | -6.35% | -0.30% | 5.0分 |
| 22 | 新华制药 | -6.94% | -1.57% | 4.2分 |
| 24 | 威尔药业 | -7.18% | -0.51% | 5.5分 |
| 26 | ST人福 | -7.34% | -0.85% | 4.4分 |
| 28 | 福安药业 | -7.56% | 0.00% | 5.0分 |
| 30 | 海翔药业 | -7.68% | 7.85% | 5.4分 |
| 32 | 健康元 | -7.93% | -0.89% | 4.5分 |
| 34 | ST能特 | -8.33% | 5.96% | 4.2分 |
| 36 | 诚意药业 | -8.59% | 1.40% | 4.9分 |
| 38 | - | -8.65% | 0.11% | 分 |
| 40 | 海欣股份 | -8.80% | -1.92% | 4.9分 |
| 42 | 赛分科技 | -9.15% | -9.19% | 4.8分 |
| 44 | 新和成 | -9.37% | 0.70% | 4.9分 |
| 46 | 圣诺生物 | -9.52% | -3.76% | 4.9分 |
| 48 | 溢多利 | -9.69% | -3.35% | 4.7分 |
| 50 | ST复华 | -9.74% | -2.57% | 3.6分 |
| 52 | 一品红 | -9.89% | -5.44% | 5.5分 |
| 54 | - | -10.19% | 0.75% | 分 |
| 56 | 哈三联 | -10.31% | 1.28% | 4.4分 |
| 58 | 复星医药 | -10.46% | -4.89% | 4.1分 |
| 60 | - | -10.78% | 1.85% | 分 |
| 62 | 艾力斯 | -10.92% | -5.51% | 4.7分 |
| 64 | 中关村 | -11.21% | 0.48% | 5.1分 |
| 66 | 广济药业 | -11.66% | -4.35% | 4.4分 |
| 68 | 海普瑞 | -11.69% | -2.32% | 5.3分 |
| 70 | 泽璟制药 | -11.81% | -7.22% | 4.6分 |
| 72 | ST惠程 | -12.18% | -1.32% | 5.1分 |
| 74 | 三圣股份 | -12.29% | -2.36% | 4.0分 |
| 76 | - | -12.58% | 1.21% | 分 |
| 78 | 力生制药 | -12.68% | -0.75% | 5.1分 |
| 80 | 复旦张江 | -12.73% | -5.28% | 4.9分 |
| 82 | 吉贝尔 | -12.82% | -1.84% | 4.4分 |
| 84 | 小方制药 | -12.86% | -1.72% | 4.1分 |
| 86 | 川宁生物 | -13.20% | -3.34% | 3.9分 |
| 88 | 同和药业 | -13.23% | -2.62% | 4.7分 |
| 90 | 舒泰神 | -13.36% | 4.35% | 3.9分 |
| 92 | - | -13.38% | 0.43% | 分 |
| 94 | 西点药业 | -13.81% | -2.92% | 4.1分 |
| 96 | 卫信康 | -14.00% | -0.54% | 4.8分 |
| 98 | 凯因科技 | -14.31% | -2.64% | 4.2分 |
| 100 | 海正药业 | -14.41% | -3.60% | 4.4分 |
| 102 | 宣泰医药 | -14.48% | -3.53% | 4.4分 |
| 104 | 海森药业 | -14.57% | -4.78% | 4.2分 |
| 106 | 誉衡药业 | -14.66% | -2.02% | 5.1分 |
| 108 | 拓新药业 | -14.76% | -1.52% | 3.5分 |
| 110 | 北大医药 | -14.94% | -0.76% | 4.5分 |
| 112 | 华东医药 | -15.26% | -3.98% | 4.9分 |
| 114 | 莎普爱思 | -15.57% | -3.59% | 4.4分 |
| 116 | 悦康药业 | -15.82% | -9.01% | 5.0分 |
| 118 | 首药控股 | -16.01% | -9.00% | 4.1分 |
| 120 | 向日葵 | -16.12% | -1.77% | 3.7分 |
| 122 | 常山药业 | -16.18% | -1.21% | 4.2分 |
| 124 | 北陆药业 | -16.25% | -2.65% | 4.3分 |
| 126 | 新天地 | -16.48% | -3.51% | 4.1分 |
| 128 | 本立科技 | -16.96% | -4.78% | 4.4分 |
| 130 | 赛托生物 | -17.11% | -3.82% | 4.3分 |
| 132 | 汇宇制药 | -17.31% | -8.64% | 4.8分 |
| 134 | 广生堂 | -17.70% | -16.13% | 4.4分 |
| 136 | 海南海药 | -18.24% | 0.25% | 4.7分 |
| 138 | 富祥股份 | -18.45% | 3.55% | 4.9分 |
| 140 | 司太立 | -18.82% | -7.66% | 4.1分 |
| 142 | 莱美药业 | -19.91% | -9.52% | 4.0分 |
| 144 | 益方生物 | -21.15% | -9.69% | 4.2分 |
| 146 | 润都股份 | -22.23% | -2.70% | 4.5分 |
| 148 | 上海谊众 | -22.72% | -28.40% | 4.1分 |
| 150 | 苑东生物 | -23.99% | -6.12% | 4.6分 |
| 152 | 罗欣药业 | -24.91% | -1.87% | 5.1分 |
| 154 | 迪哲医药 | -26.40% | -22.64% | 5.0分 |
| 156 | *ST赛隆 | -28.14% | -22.65% | 4.1分 |
| 158 | 信立泰 | -35.46% | -3.55% | 4.9分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信建投 | 2012-09-10 | 增持 | 增持 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 申银万国 | 2012-09-10 | 增持 | 增持 |
| 国都证券 | 2012-09-10 | 增持 | - |
| 长江证券 | 2012-09-09 | 增持 | 增持 |
更多>>行业资讯
- 2012-09-13科达机电稳步上涨 3大业务或刺激业绩大增
- 2012-09-13二重重装职工董事辞职及增补职工董事
- 2012-09-13凤凰光学修订<公司章程>部分条款
- 2012-09-13南通锻压：使用募集资金对南通锻压设备（天津）有限公
- 2012-09-13华中数控：重大资产重组进展
- 2012-09-13华西能源：获得中国证监会核准公开发行公司债券批复
- 2012-09-13海源机械：持股5%以上股东减持股份
- 2012-09-13中原内配：通过德国DaimlerAG（戴姆勒有限公
- 2012-09-13杰瑞股份：重大事项停牌
- 2012-09-13航天科技：股票交易异常波动
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 114/218 ， 35/218。
[{"date":"2026-03-31","value":"0.35","vol":"0.43"},{"date":"2025-12-31","value":"-154.16","vol":"-2.03"},{"date":"2025-09-30","value":"-74.84","vol":"1.53"},{"date":"2025-06-30","value":"-49.70","vol":"1.24"},{"date":"2025-03-31","value":"-15.69","vol":"-0.13"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
0.35 | -154.16 | -74.84 | -49.70 | -15.69 |
| 行业(%) | 0.43 | -2.03 | 1.53 | 1.24 | -0.13 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"69.24","vol":"50.72"},{"date":"2025-12-31","value":"62.89","vol":"49.72"},{"date":"2025-09-30","value":"64.64","vol":"49.60"},{"date":"2025-06-30","value":"65.33","vol":"49.57"},{"date":"2025-03-31","value":"66.62","vol":"49.06"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
69.24 | 62.89 | 64.64 | 65.33 | 66.62 |
| 行业(%) | 50.72 | 49.72 | 49.60 | 49.57 | 49.06 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 52/218 ， 20/218。
[{"date":"2026-03-31","value":"7.42","vol":"25.51"},{"date":"2025-12-31","value":"-9.11","vol":"38.97"},{"date":"2025-09-30","value":"-7.75","vol":"141.63"},{"date":"2025-06-30","value":"-9.47","vol":"78.56"},{"date":"2025-03-31","value":"-0.46","vol":"0.01"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
7.42 | -9.11 | -7.75 | -9.47 | -0.46 |
| 行业(%) | 25.51 | 38.97 | 141.63 | 78.56 | 0.01 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"130.84","vol":"47.13"},{"date":"2025-12-31","value":"-153.11","vol":"-26.11"},{"date":"2025-09-30","value":"8.71","vol":"-2.93"},{"date":"2025-06-30","value":"1.47","vol":"59.61"},{"date":"2025-03-31","value":"-960.04","vol":"-10.40"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
130.84 | -153.11 | 8.71 | 1.47 | -960.04 |
| 行业(%) | 47.13 | -26.11 | -2.93 | 59.61 | -10.40 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 118/218 ， 32/218。
[{"date":"2026-03-31","value":"0.06","vol":"0.10"},{"date":"2025-12-31","value":"0.43","vol":"0.41"},{"date":"2025-09-30","value":"0.30","vol":"0.31"},{"date":"2025-06-30","value":"0.20","vol":"0.21"},{"date":"2025-03-31","value":"0.11","vol":"0.10"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.06 | 0.43 | 0.30 | 0.20 | 0.11 |
| 行业(次) | 0.10 | 0.41 | 0.31 | 0.21 | 0.10 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.89","vol":"0.65"},{"date":"2025-12-31","value":"3.38","vol":"2.58"},{"date":"2025-09-30","value":"2.01","vol":"1.93"},{"date":"2025-06-30","value":"1.39","vol":"1.29"},{"date":"2025-03-31","value":"0.73","vol":"0.66"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.89 | 3.38 | 2.01 | 1.39 | 0.73 |
| 行业(次) | 0.65 | 2.58 | 1.93 | 1.29 | 0.66 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"-66.52","vol":"-2.81"},{"date":"2025-12-31","value":"27.37","vol":"16.49"},{"date":"2025-09-30","value":"36.07","vol":"4.26"},{"date":"2025-06-30","value":"-15.76","vol":"2.95"},{"date":"2025-03-31","value":"11.44","vol":"-26.33"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -66.52 | 27.37 | 36.07 | -15.76 | 11.44 |
| 行业 | -2.81 | 16.49 | 4.26 | 2.95 | -26.33 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.14","vol":"1.60"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.04","vol":"1.71"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.14 | - | 0.04 | - |
| 行业 | 0.00 | 1.60 | 0.00 | 1.71 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 116/218 ， 125/218。
[{"date":"2026-03-31","value":"4.47","vol":"3.57"},{"date":"2025-12-31","value":"0.34","vol":"3.31"},{"date":"2025-09-30","value":"0.39","vol":"3.48"},{"date":"2025-06-30","value":"0.19","vol":"3.66"},{"date":"2025-03-31","value":"0.24","vol":"3.57"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
4.47 | 0.34 | 0.39 | 0.19 | 0.24 |
| 行业 | 3.57 | 3.31 | 3.48 | 3.66 | 3.57 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"4.36","vol":"2.93"},{"date":"2025-12-31","value":"0.28","vol":"2.69"},{"date":"2025-09-30","value":"0.30","vol":"2.73"},{"date":"2025-06-30","value":"0.12","vol":"2.88"},{"date":"2025-03-31","value":"0.17","vol":"2.80"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
4.36 | 0.28 | 0.30 | 0.12 | 0.17 |
| 行业 | 2.93 | 2.69 | 2.73 | 2.88 | 2.80 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 108/218 ， 114/218。
[{"date":"2026-03-31","value":"18.86","vol":"33.54"},{"date":"2025-12-31","value":"103.45","vol":"34.70"},{"date":"2025-09-30","value":"104.30","vol":"34.06"},{"date":"2025-06-30","value":"105.23","vol":"34.12"},{"date":"2025-03-31","value":"102.85","vol":"34.09"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
18.86 | 103.45 | 104.30 | 105.23 | 102.85 |
| 行业(%) | 33.54 | 34.70 | 34.06 | 34.12 | 34.09 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.23","vol":"9.77"},{"date":"2025-12-31","value":"36.65","vol":"1.76"},{"date":"2025-09-30","value":"24.55","vol":"1.19"},{"date":"2025-06-30","value":"19.32","vol":"0.87"},{"date":"2025-03-31","value":"13.58","vol":"1.44"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.23 | 36.65 | 24.55 | 19.32 | 13.58 |
| 行业(%) | 9.77 | 1.76 | 1.19 | 0.87 | 1.44 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"-1.23","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-2.36","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.52","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-0.81","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]